{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:57:03Z","timestamp":1789790223935,"version":"4.0.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T00:00:00Z","timestamp":1638230400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA068485"],"award-info":[{"award-number":["P30CA068485"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-18-1-0029"],"award-info":[{"award-number":["W81XWH-18-1-0029"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bone Oncology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jbo.2021.100407","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T03:04:34Z","timestamp":1638327874000},"page":"100407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["HDAC inhibitors stimulate LIFR when it is repressed by hypoxia or PTHrP in breast cancer"],"prefix":"10.1016","volume":"31","author":[{"given":"Courtney M.","family":"Edwards","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda E.","family":"Clements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Lawrence A.","family":"Vecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachelle W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jbo.2021.100407_b0005","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1080\/15384047.2018.1456599","article-title":"Breast cancer lung metastasis: Molecular biology and therapeutic implications","volume":"19","author":"Jin","year":"2018","journal-title":"Cancer Biology & Therapy"},{"issue":"2","key":"10.1016\/j.jbo.2021.100407_b0010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/joim.12084","article-title":"Breast cancer as a systemic disease: a view of metastasis","volume":"274","author":"Redig","year":"2013","journal-title":"J Intern Med"},{"issue":"9","key":"10.1016\/j.jbo.2021.100407_b0015","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrc3793","article-title":"Mechanisms of disseminated cancer cell dormancy: an awakening field","volume":"14","author":"Sosa","year":"2014","journal-title":"Nature reviews. Cancer"},{"issue":"4","key":"10.1016\/j.jbo.2021.100407_b0020","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrc2627","article-title":"Parallel progression of primary tumours and metastases","volume":"9","author":"Klein","year":"2009","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10.1016\/j.jbo.2021.100407_b0025","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nrclinonc.2009.44","article-title":"Cancer micrometastases","volume":"6","author":"Pantel","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"10.1016\/j.jbo.2021.100407_b0030","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nrc1370","article-title":"Dissecting the metastatic cascade","volume":"4","author":"Pantel","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"10.1016\/j.jbo.2021.100407_b0035","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/bjc.2014.5","article-title":"Time-dependent risk of developing distant metastasis in breast cancer patients according to treatment, age and tumour characteristics","volume":"110","author":"Colzani","year":"2014","journal-title":"British journal of cancer"},{"issue":"2","key":"10.1016\/j.jbo.2021.100407_b0040","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.canlet.2009.02.028","article-title":"HDACi\u2013targets beyond chromatin","volume":"280","author":"Buchwald","year":"2009","journal-title":"Cancer Lett"},{"issue":"3","key":"10.1016\/j.jbo.2021.100407_b0045","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s11914-021-00670-2","article-title":"Targeting Histone Modifications in Bone and Lung Metastatic Cancers","volume":"19","author":"Edwards","year":"2021","journal-title":"Current Osteoporosis Reports"},{"key":"10.1016\/j.jbo.2021.100407_b0050","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.breast.2018.12.001","article-title":"The role of histone deacetylase inhibitors in metastatic breast cancer","volume":"43","author":"Zucchetti","year":"2019","journal-title":"The Breast"},{"key":"10.1016\/j.jbo.2021.100407_b0055","first-page":"37","article-title":"Romidepsin in the treatment of cutaneous T-cell lymphoma","volume":"2","author":"Jain","year":"2011","journal-title":"Journal of blood medicine"},{"issue":"10","key":"10.1016\/j.jbo.2021.100407_b0060","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1634\/theoncologist.12-10-1247","article-title":"FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma","volume":"12","author":"Mann","year":"2007","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.jbo.2021.100407_b0065","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1634\/theoncologist.2017-0644","article-title":"Panobinostat and Multiple Myeloma in 2018","volume":"23","author":"Yee","year":"2018","journal-title":"The oncologist"},{"issue":"3","key":"10.1016\/j.jbo.2021.100407_b0070","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ccell.2016.08.001","article-title":"Feedback Activation of Leukemia Inhibitory Factor Receptor Limits Response to Histone Deacetylase Inhibitors in Breast Cancer","volume":"30","author":"Zeng","year":"2016","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.jbo.2021.100407_b0075","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1158\/1078-0432.CCR-08-2786","article-title":"Rational Combinations Using HDAC Inhibitors","volume":"15","author":"Bots","year":"2009","journal-title":"Clinical Cancer Research"},{"issue":"10","key":"10.1016\/j.jbo.2021.100407_b0080","doi-asserted-by":"crossref","first-page":"a026831","DOI":"10.1101\/cshperspect.a026831","article-title":"HDACs and HDAC Inhibitors in Cancer Development and Therapy","volume":"6","author":"Li","year":"2016","journal-title":"Cold Spring Harbor perspectives in medicine"},{"key":"10.1016\/j.jbo.2021.100407_b0085","doi-asserted-by":"crossref","unstructured":"R.M. Connolly et al. E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group J Clin Oncol 2021 p. Jco2100944","DOI":"10.1200\/JCO.21.00944"},{"issue":"34","key":"10.1016\/j.jbo.2021.100407_b0090","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1038\/s41388-021-01931-1","article-title":"HDAC inhibitors induce LIFR expression and promote a dormancy phenotype in breast cancer","volume":"40","author":"Clements","year":"2021","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.jbo.2021.100407_b0095","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/ncb3408","article-title":"Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow","volume":"18","author":"Johnson","year":"2016","journal-title":"Nature cell biology"},{"issue":"10","key":"10.1016\/j.jbo.2021.100407_b0100","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/nm.2940","article-title":"LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker","volume":"18","author":"Chen","year":"2012","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.jbo.2021.100407_b0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10549-012-2068-7","article-title":"Whole genome in vivo RNAi screening identifies the leukemia inhibitory factor receptor as a novel breast tumor suppressor","volume":"135","author":"Iorns","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.jbo.2021.100407_b0110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11914-017-0378-8","article-title":"Hypoxia and Bone Metastatic Disease","volume":"15","author":"Johnson","year":"2017","journal-title":"Current osteoporosis reports"},{"issue":"3","key":"10.1016\/j.jbo.2021.100407_b0115","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1152\/physrev.00031.2015","article-title":"Parathyroid Hormone-Related Protein, Its Regulation of Cartilage and Bone Development, and Role in Treating Bone Diseases","volume":"96","author":"Martin","year":"2016","journal-title":"Physiol Rev"},{"issue":"9","key":"10.1016\/j.jbo.2021.100407_b0120","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1111\/bph.14709","article-title":"Multiple actions of parathyroid hormone-related protein in breast cancer bone metastasis","volume":"178","author":"Martin","year":"2021","journal-title":"British Journal of Pharmacology"},{"issue":"S8","key":"10.1016\/j.jbo.2021.100407_b0125","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.0.CO;2-I","article-title":"Mechanisms of bone metastasis","volume":"80","author":"Mundy","year":"1997","journal-title":"Cancer"},{"issue":"15","key":"10.1016\/j.jbo.2021.100407_b0130","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1158\/0008-5472.CAN-07-6849","article-title":"Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton","volume":"68","author":"Barkan","year":"2008","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.jbo.2021.100407_b0135","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1210\/endo.140.10.7037","article-title":"Breast cancer cells interact with osteoblasts to support osteoclast formation","volume":"140","author":"Thomas","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.jbo.2021.100407_b0140","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2018.00241","article-title":"Parathyroid Hormone-Related Protein Negatively Regulates Tumor Cell Dormancy Genes in a PTHR1\/Cyclic AMP-Independent Manner","volume":"9","author":"Johnson","year":"2018","journal-title":"Frontiers in endocrinology"},{"issue":"3","key":"10.1016\/j.jbo.2021.100407_b0145","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/jnci\/93.3.234","article-title":"Parathyroid Hormone-Related Protein Production by Breast Cancers, Improved Survival, and Reduced Bone Metastases","volume":"93","author":"Henderson","year":"2001","journal-title":"JNCI: Journal of the National Cancer Institute"},{"issue":"10","key":"10.1016\/j.jbo.2021.100407_b0150","first-page":"3172","article-title":"Coexpression of parathyroid hormone related protein and its receptor in early breast cancer predicts poor patient survival","volume":"8","author":"Linforth","year":"2002","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10.1016\/j.jbo.2021.100407_b0155","first-page":"1684","article-title":"ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK)","volume":"63","author":"Aguirre-Ghiso","year":"2003","journal-title":"Cancer Res"},{"issue":"15","key":"10.1016\/j.jbo.2021.100407_b0160","doi-asserted-by":"crossref","first-page":"8711","DOI":"10.1073\/pnas.96.15.8711","article-title":"Cancer dormancy and cell signaling: induction of p21(waf1) initiated by membrane IgM engagement increases survival of B lymphoma cells","volume":"96","author":"Marches","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"11","key":"10.1016\/j.jbo.2021.100407_b0165","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/ncb2861","article-title":"TGF-\u03b22 dictates disseminated tumour cell fate in target organs through TGF-\u03b2-RIII and p38\u03b1\/\u03b2 signalling","volume":"15","author":"Bragado","year":"2013","journal-title":"Nat Cell Biol"},{"issue":"4","key":"10.1016\/j.jbo.2021.100407_b0170","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1091\/mbc.12.4.863","article-title":"Urokinase Receptor and Fibronectin Regulate the ERKMAPK to p38MAPK Activity Ratios That Determine Carcinoma Cell Proliferation or Dormancy In Vivo","volume":"12","author":"Aguirre-Ghiso","year":"2001","journal-title":"Molecular Biology of the Cell"},{"issue":"14","key":"10.1016\/j.jbo.2021.100407_b0175","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1158\/0008-5472.CAN-08-3820","article-title":"Computational identification of a p38SAPK-regulated transcription factor network required for tumor cell quiescence","volume":"69","author":"Adam","year":"2009","journal-title":"Cancer research"},{"issue":"17","key":"10.1016\/j.jbo.2021.100407_b0180","first-page":"5076","article-title":"Constitutive p38HOG Mitogen-activated Protein Kinase Activation Induces Permanent Cell Cycle Arrest and Senescence","volume":"62","author":"Haq","year":"2002","journal-title":"Cancer Research"},{"issue":"18","key":"10.1016\/j.jbo.2021.100407_b0185","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1158\/1078-0432.CCR-10-2574","article-title":"ERK1\/2 and p38\u03b1\/\u03b2 signaling in tumor cell quiescence: opportunities to control dormant residual disease","volume":"17","author":"Sosa","year":"2011","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"issue":"4","key":"10.1016\/j.jbo.2021.100407_b0190","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.molcel.2008.07.002","article-title":"Lysine acetylation: codified crosstalk with other posttranslational modifications","volume":"31","author":"Yang","year":"2008","journal-title":"Mol Cell"},{"issue":"4","key":"10.1016\/j.jbo.2021.100407_b0195","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.bjc.6600757","article-title":"The parathyroid hormone-related protein receptor is expressed in breast cancer bone metastases and promotes autocrine proliferation in breast carcinoma cells","volume":"88","author":"Hoey","year":"2003","journal-title":"British Journal of Cancer"},{"issue":"4","key":"10.1016\/j.jbo.2021.100407_b0200","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ijc.11586","article-title":"Parathyroid hormone-related protein (PTHrP) is responsible for production of bone metastasis, but not visceral metastasis, by human small cell lung cancer SBC-5 cells in natural killer cell-depleted SCID mice","volume":"108","author":"Miki","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jbo.2021.100407_b0205","doi-asserted-by":"crossref","unstructured":"Wulf, G.G., et al., Reverse transcriptase\/polymerase chain reaction analysis of parathyroid hormone-related protein for the detection of tumor cell dissemination in the peripheral blood and bone marrow of patients with breast cancer. Journal of Cancer Research and Clinical Oncology, 1997. 123(9): p. 514-521.","DOI":"10.1007\/s004320050097"},{"key":"10.1016\/j.jbo.2021.100407_b0210","doi-asserted-by":"crossref","unstructured":"F. de Miguel N. Fiaschi-Taesch J.C. L\u00f3pez-Talavera K.K. Takane T. Massfelder J.-J. Helwig A.F. Stewart The C-terminal region of PTHrP, in addition to the nuclear localization signal, is essential for the intracrine stimulation of proliferation in vascular smooth muscle cells 142 9 2001 4096 4105","DOI":"10.1210\/endo.142.9.8388"},{"issue":"1","key":"10.1016\/j.jbo.2021.100407_b0215","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00666208","article-title":"Osteolytic bone metastasis in breast cancer","volume":"32","author":"Yoneda","year":"1994","journal-title":"Breast Cancer Research and Treatment"},{"issue":"67","key":"10.1016\/j.jbo.2021.100407_b0220","doi-asserted-by":"crossref","DOI":"10.3791\/4260","article-title":"Models of bone metastasis","author":"Campbell","year":"2012","journal-title":"J Vis Exp"},{"issue":"2","key":"10.1016\/j.jbo.2021.100407_b0225","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/08977194.2014.894037","article-title":"Bone-derived soluble factors and laminin-511 cooperate to promote migration, invasion and survival of bone-metastatic breast tumor cells AU \u2013 Denoyer, Delphine","volume":"32","author":"Kusuma","year":"2014","journal-title":"Growth Factors"},{"key":"10.1016\/j.jbo.2021.100407_b0230","doi-asserted-by":"crossref","unstructured":"Ansari, N., et al., Autocrine and Paracrine Regulation of the Murine Skeleton by Osteocyte-Derived Parathyroid Hormone-Related Protein. 2018. 33(1): p. 137-153","DOI":"10.1002\/jbmr.3291"},{"issue":"1","key":"10.1016\/j.jbo.2021.100407_b0235","doi-asserted-by":"crossref","DOI":"10.1038\/srep04012","article-title":"A novel cell-cycle-indicator, mVenus-p27K-, identifies quiescent cells and visualizes G0\u2013G1 transition","volume":"4","author":"Oki","year":"2015","journal-title":"Scientific reports"},{"key":"10.1016\/j.jbo.2021.100407_b0240","doi-asserted-by":"crossref","unstructured":"V. Richard A. Luchin R.M. Brena C. Plass T.J. Rosol Quantitative evaluation of alternative promoter usage and 3' splice variants for parathyroid hormone-related protein by real-time reverse transcription-PCR 49 8 2003 2003 1398 1402","DOI":"10.1373\/49.8.1398"},{"issue":"6","key":"10.1016\/j.jbo.2021.100407_b0245","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/s41388-019-1064-3","article-title":"PREX1 drives spontaneous bone dissemination of ER+ breast cancer cells","volume":"39","author":"Clements","year":"2020","journal-title":"Oncogene"}],"container-title":["Journal of Bone Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137421000622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137421000622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T20:20:44Z","timestamp":1761942044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212137421000622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":49,"alternative-id":["S2212137421000622"],"URL":"https:\/\/doi.org\/10.1016\/j.jbo.2021.100407","relation":{},"ISSN":["2212-1374"],"issn-type":[{"value":"2212-1374","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HDAC inhibitors stimulate LIFR when it is repressed by hypoxia or PTHrP in breast cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Bone Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbo.2021.100407","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"100407"}}